You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
VIEW TAGS
Articles tagged ‘acute coronary syndrome’
May 2012
Br J Cardiol 2012;19:85–9
Drugs for diabetes: part 9 prescribing for patients with cardiac disease
Up to one-third of patients with heart disease have diabetes. Cardiological status should be considered when deciding on treatment for diabetes. Patients with stable coronary
March 2012
Br J Cardiol 2012;19:24
Current prescribing of statins and persistence to statins following ACS in the UK: a MINAP/GPRD study
National Institute for Health and Clinical Excellence (NICE) guideline CG67 recommends that acute coronary syndrome (ACS) cases are treated with high-intensity statins (defined as statins
June 2011
Br J Cardiol 2011;18:105–8
News from the American College of Cardiology Scientific Session 2011
Highlights of the recent American College of Cardiology (ACC) meeting, held in New Orleans, USA, on 2nd – 5th April 2011, included the promise of
April 2011
Br J Cardiol 2011;18:84−7
Clopidogrel and proton-pump inhibitor interaction: viewpoint and practical clinical approach
The role of clopidogrel after percutaneous coronary intervention (PCI) or acute coronary syndrome (ACS) is well supported by strong clinical evidence, which has led to
April 2011
Br J Cardiol 2011;18:82–3
Dose capping of enoxaparin results in sub-therapeutic anti-Xa level
Enoxaparin is recommended for treatment of patients with acute coronary syndromes (ACS). While plasma monitoring of enoxaparin is not usually required, it may be assessed
September 2010
Br J Cardiol 2010;17:211-14
News from the 2010 Congress of the European Society of Cardiology
News from the world of cardiology.
September 2010
Br J Cardiol 2010;17:s3-s4
PCI in the UK – the continuing journey
A new and exciting ‘journey’ in interventional cardiology began more than 20 years ago with the introduction of intracoronary stenting.
September 2010
Br J Cardiol 2010;17:s5-s8
Intervention: who to treat and how?
Treatment options in ACS include optimised medical therapy, intervention and surgical revascularisation.
September 2010
Br J Cardiol 2010;17:s9-s14
Optimising medical treatment of ACS
The first widely used antiplatelet agent, aspirin, continues to be standard therapy in ACS patients. The meta-analysis of the Antithrombotic Trialists’ Collaboration showed a 40%